Leucine Enkephalin (Leu-ENK) Antibody
299€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Leucine Enkephalin (Leu-ENK) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx178998
tested applications
WB, IHC, IF/ICC
Description
Leucine-Enkephalin (Leu-ENK) Antibody is a Rabbit Polyclonal antibody against Leucine-Enkephalin (Leu-ENK).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Leucine Enkephalin (Leu-ENK) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Size 1 | 100 µl |
| Size 2 | 200 µl |
| Size 3 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-7 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Alias | ENK |
| Background | Antibody anti-ENK |
| Status | RUO |
Descripción
Enkephalins (ENK)are endogenous opioid peptides that function as neurotransmitters and neuromodulators in the central and peripheral nervous systems. They are derived from precursor proteins such as proenkephalin and act on opioid receptors, particularly the delta-opioid receptor, to modulate pain, stress, mood, and immune responses. Enkephalins are widely distributed in brain regions involved in pain perception, including the spinal cord and limbic system, and are released in response to stress or injury to provide analgesic and anxiolytic effects. Beyond their role in pain modulation, enkephalins regulate gastrointestinal motility, cardiovascular function, and immune activity. Dysregulation of enkephalin levels is associated with chronic pain syndromes, mood disorders, and addiction. Enkephalins are also being investigated for therapeutic use in conditions such as neuropathic pain, where targeting the endogenous opioid system can provide relief without the adverse effects associated with exogenous opioids.
